The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

Retrieved on: 2022-05-13 17:36:27

Tags for this article:

Click the tags to see associated articles and topics

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11. View article details on hiswai:

Excerpt

These children received two doses of mRNA-1273 vaccine or placebo of 50 μg each at an interval of 28 days. The team then followed for 82 days on ...

Article found on: www.news-medical.net